Literature DB >> 402547

Erythromycin resistant mutations in Bacillus subtilis cause temperature sensitive sporulation.

D J Tipper, C W Johnson, C L Ginther, T Leighton, H G Wittmann.   

Abstract

All of several hundred erythromycin resistant single site mutants of Bacillus subtilis W168 are temperature senstive for sporulation. The mutants and wild type cells grow vegetatively at essentially the same rates at both permissive (30 degrees C) and nonpermissive (47 degrees C) temperatures. In addition cellular protein synthesis, cell mass increases and cell viabilities are similar in mutant and wild type strains for several hours after the end of vegetative growth (47 degrees C). in the mutants examined, the temperature sensitive periods begin when the sporulation process is approximately 40% completed, and end when the process is 90% completed. At nonpermissive temperatures, the mutants produce serine and metal proteases at 50% of the wild type rate, accumulate serine esterase at 16% of the wild type rate, and do not demonstrate a sporulation related increase in alkaline phosphatase activity. The eryR and spots phenotypes cotransform 100%, and cotransduce 100% using phage PBS1. Revertants selected for ability to sporulate normally at 47 degrees C (spot), simultaneously regain parental sensitivity to erthromycin. No second site revertants are found. Ribosomes from eryR spots strains bind erythromycin at less than 1% of the wild type rate. A single 50S protein (L17) from mutant ribosomes shows an altered electrophoretic mobility. Ribosomes from spo+ revertants bind erythromycin like parental ribosomes and their proteins are electrophoretically identical to wild type. These data indicate that the L17 protein of the 50S ribosomal subunit from Bacillus subtilis may participate specifically in the sporulation process.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402547     DOI: 10.1007/bf00695395

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  27 in total

1.  Translation initiation defects in ribosomes from streptomycin dependent strains.

Authors:  M Lazar; F Gros
Journal:  Biochimie       Date:  1973       Impact factor: 4.079

2.  Chromosomal location of antibiotic resistance markers in Bacillus subtilis.

Authors:  N Harford; N Sueoka
Journal:  J Mol Biol       Date:  1970-07-28       Impact factor: 5.469

3.  Alteration of the ribosomal fraction of Bacillus subtilis during sporulation.

Authors:  P Fortnagel; R Bergmann
Journal:  Biochim Biophys Acta       Date:  1973-02-23

4.  Erythromycin resistant mutants of Bacillus subtilis.

Authors:  K Tanaka; M Tamaki; S Osawa; A Kimura; R Takata
Journal:  Mol Gen Genet       Date:  1973-12-20

5.  Sporulation-specific translational discrimination in Bacillus subtilis.

Authors:  T Leighton
Journal:  J Mol Biol       Date:  1974-07-15       Impact factor: 5.469

6.  Studies on the control of development. In vitro synthesis of HPN and MS nucleotides by ribosomes from either sporulating or vegetative cells of Bacillus subtilis.

Authors:  H J Rhaese; R Groscurth
Journal:  FEBS Lett       Date:  1974-08-15       Impact factor: 4.124

7.  Ribosomal proteins of Bacillus subtilis vegetative and sporulating cells.

Authors:  S Guha
Journal:  Mol Gen Genet       Date:  1975-07-10

8.  RIBONUCLEIC ACIDS OF BACILLUS SUBTILIS SPORES AND SPORULATING CELLS.

Authors:  R H DOI; R T IGARASHI
Journal:  J Bacteriol       Date:  1964-02       Impact factor: 3.490

9.  Division mutants of Bacillus subtilis: isolation and PBS1 transduction of division-specific markers.

Authors:  D Van Alstyne; M I Simon
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

10.  A mutant of Escherichia coli with temperature-sensitive streptomycin protein.

Authors:  S S Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

View more
  28 in total

1.  Pleiotropic effects of ribosomal mutations for cycloheximide resistance in a double-resistant homocaryon of Neurospora crassa.

Authors:  V E Vomvoyanni; M P Argyrakis
Journal:  J Bacteriol       Date:  1979-08       Impact factor: 3.490

2.  Isolation and characterization of Bacillus stearothermophilus 30S and 50S ribosomal protein mutations.

Authors:  J Schnier; H S Gewitz; S E Behrens; A Lee; C Ginther; T Leighton
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

3.  Bacillus subtilis spore coats: complexity and purification of a unique polypeptide component.

Authors:  R C Goldman; D J Tipper
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

Review 4.  Revised genetic linkage map of Bacillus subtilis.

Authors:  P J Piggot; J A Hoch
Journal:  Microbiol Rev       Date:  1985-06

5.  Isolation and molecular genetic characterization of the Bacillus subtilis gene (infB) encoding protein synthesis initiation factor 2.

Authors:  K Shazand; J Tucker; R Chiang; K Stansmore; H U Sperling-Petersen; M Grunberg-Manago; J C Rabinowitz; T Leighton
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

Review 6.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

Review 7.  The Bacillus subtilis chromosome.

Authors:  D J Henner; J A Hoch
Journal:  Microbiol Rev       Date:  1980-03

8.  Coat protein synthesis during sporulation of Bacillus subtilis: immunological detection of soluble precursors to the 12,200-dalton spore coat protein.

Authors:  R C Goldman; D J Tipper
Journal:  J Bacteriol       Date:  1981-09       Impact factor: 3.490

9.  Physiological suppression of Bacillus subtilis conditioned sporulation phenotypes: RNA polymerase and ribosomal mutations.

Authors:  R R Wayne; T Leighton
Journal:  Mol Gen Genet       Date:  1981

10.  Translational attenuation and mRNA stabilization as mechanisms of erm(B) induction by erythromycin.

Authors:  Yu-Hong Min; Ae-Ran Kwon; Eun-Jeong Yoon; Mi-Ja Shim; Eung-Chil Choi
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.